RANBAXY SDN BHD

Company Type: Manufacturer (Factory)

Introduction:

RANBAXY SDN BHD was the Malaysian subsidiary of Ranbaxy Laboratories Limited, a prominent global pharmaceutical company originally headquartered in India. The company operated as a manufacturer, focusing on the production and distribution of a diverse portfolio of pharmaceutical products within Malaysia and for export markets.

Business Scope:

Its operations in Malaysia encompassed the manufacturing of various generic and branded prescription drugs, over-the-counter medications, and other healthcare-related products. Ranbaxy was known for its commitment to providing affordable and quality medicines. While primarily a manufacturing entity (factory), it also engaged in the sales, marketing, and distribution (trading) of these products within the Malaysian healthcare sector.

Current Status Note:

It is important to note that Ranbaxy Laboratories Limited was acquired by Sun Pharmaceutical Industries Ltd. in 2014. As a result, RANBAXY SDN BHD and its operations in Malaysia are now integrated into Sun Pharmaceutical Industries Ltd.'s global network. While some products may still carry the Ranbaxy brand, the corporate entity and its manufacturing facilities are part of Sun Pharma.

Based on available information, Ranbaxy Malaysia Sdn Bhd (now Sun Pharma Malaysia) produces or sells a range of generic pharmaceutical products. These include medications in various therapeutic areas such as:

* Cardiovascular diseases

* Central nervous system disorders

* Gastrointestinal conditions

* Infections (antibiotics)

* Pain management

* Respiratory illnesses

* Dermatological conditions

* Women's health

Please note that the product portfolio may have changed since Ranbaxy was acquired by Sun Pharma. For the most up-to-date and detailed product information, it is recommended to visit the Sun Pharma Malaysia website.